A double-blind, randomized, placebo-controlled study of Ro 64-0796 (also known as GS4104) used in elderly subjects for the prevention of clinical influenza during influenza season

Trial Profile

A double-blind, randomized, placebo-controlled study of Ro 64-0796 (also known as GS4104) used in elderly subjects for the prevention of clinical influenza during influenza season

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Nov 2010

At a glance

  • Drugs Oseltamivir (Primary)
  • Indications Influenza virus infections
  • Focus Therapeutic Use
  • Sponsors Roche
  • Most Recent Events

    • 08 Nov 2010 Last checked against Rochetrials.com record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top